Genky DrugStores Extends Store Network as Same-Store Sales Level Off in February

Genky DrugStores Co., Ltd. ( (JP:9267) ) just unveiled an announcement.

Genky DrugStores reported continued top-line growth in February for all stores, with net sales up year on year and total store count rising to 503 as it opened three new standardized regular stores and recorded no closures. Existing stores saw flat year-on-year sales overall, with modest gains in customer traffic offset by slightly lower spending per customer, reflecting a stable but competitive retail environment.

For the fiscal year ending June 2026 to date, all-store net sales are showing solid double-digit growth driven by aggressive expansion, while existing-store sales are increasing at a slower low single-digit pace. The company is actively standardizing its network by converting larger outlets into regular stores and maintaining low closure numbers, indicating a focus on scale, format efficiency and steady same-store performance rather than sharp productivity gains per customer.

The most recent analyst rating on (JP:9267) stock is a Buy with a Yen4972.00 price target. To see the full list of analyst forecasts on Genky DrugStores Co., Ltd. stock, see the JP:9267 Stock Forecast page.

More about Genky DrugStores Co., Ltd.

Genky DrugStores Co., Ltd. operates a chain of drugstores and general merchandise outlets in Japan, focusing on standardized 300-tsubo regular stores. The company is pursuing a strategy of network expansion and store format standardization, including refurbishing larger formats into regular stores to enhance operational efficiency and consistency across its portfolio.

Average Trading Volume: 94,449

Technical Sentiment Signal: Buy

Current Market Cap: Yen136.8B

For detailed information about 9267 stock, go to TipRanks’ Stock Analysis page.